References
1. L. Galambos, What are the Prospects for a New Golden Era in Vaccines? (UK Vaccines Group, UK, 2008).
2. Pharmaletter website, "Novartis' flu vaccines suspended in several countries on suspected quality issues",
http://www.thepharmaletter.com/, accessed 12 Dec., 2012.
3. Fiercepharma website, "Italy bans Novartis vaccines even after company assures their safety",
http://www.fiercepharma.com/, accessed 12 Dec., 2012.
4. Reuters website, "France halts sale of Novartis flu vaccine", http://uk.reuters.com/, accessed 12 Dec., 2012.
5. Deutsche Welle website, "Germany moves to cut off vaccine shortage",
http://www.dw.de/, accessed 12 Dec., 2012.
6. The Globe and Mail website, "Canada suspends distribution of Novartis flu shots",
http://www.theglobeandmail.com/, accessed 12 Dec., 2012.
7. Fiercepharma website, "Novartis plant delay, vaccine woes steal spotlight",
http://www.fiercepharma.com/, accessed 12 Dec., 2012.
8. Health Canada website, "Health Canada Endorsed Important Safety Information on Infanrix Hexa",
http://www.hc-sc.gc.ca/, accessed 12 Dec., 2012.
9. In-pharmatechnologist website, "GSK pulls vaccine batch in Canada over contamination concerns",
http://www.in-pharmatechnologist.com/, accessed 12 Dec., 2012.
|
